1. All Products
  2. DVAC - Vaccines
  3. VACCINE MEASLES/ RUBELLA, 1 dose, multidose vial
Public Pricelist

VACCINE MEASLES/ RUBELLA, 1 dose, multidose vial

https://medicalguidelines.msf.org/en/node/965
https://unicat.msf.org/cat/product/48778
STD DVACVMER1VD

Valid Article

Former Code(s): DVACZBE0008
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
19.3 - Vaccines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J07BD53
Anatomical Therapeutic Chemical Classification according to WHOCC
0208
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

VACCINE MEASLES/RUBELLA

CAUTION

This multidose vaccine is worded and codified by unit (= 1 dose) to make the order easier.

Therapeutic Action

Freeze-dried vaccine prepared from live-attenuated strains of measles virus and rubella virus.

Indications

Active immunisation against measles and rubella

Countries are gradually replacing the measles vaccine with the measles/rubella vaccine.

The choice between measles and measles/rubella vaccine will depend on the vaccine used and registered in the country where it will be used.

Instructions for use

Reconstitute the powder vial with the diluent supplied by the manufacturer.

Must be given by SC or IM route, preferably in the upper arm.

Follow the national immunisation schedule, or failing that, the WHO schedule.

Do not forget to order the diluent together with the vaccine!

Orders are always done in number of doses and not in number of vials! (See Preliminary remarks on Vaccines)

Precautions for Use

As with all injectable vaccines and/or immunoglobulins, appropriate medical treatment should always be readily available in case of rare anaphylactic reactions following the administration of the product.

Storage

  • Powder: between 2°C and 8°C - Protect from sunlight
  • Diluent: a cold chain is not required for the storage. However, at least 12 hrs before reconstitution of the vaccine, the diluent must be refrigerated between 2°C and 8°C so that the diluent and lyophilised powder are at the same temperature (a thermic shock during reconstitution could reduce the vaccine efficacy). Do not freeze.
  • Vaccine reconstituted: between 2ºC and 8°C for maximum 6 hrs, protected from light.

(Cf Introduction: Thermosensitive products)